The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2023 AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF).
Donor Name: Health Resources and Services Administration
State: All States
County: All counties
Territory: Commonwealth of Puerto Rico, U.S. Virgin Islands, Guam, American Samoa, Commonwealth of the Northern Mariana Islands, Republic of Palau, Federated States of Micronesia and Republic of the Marshall Islands
Type of Grant: Grant
Deadline: 10/11/2022
Size of the Grant: $10,000,000
Grant Duration: 1 year
Details:
The purpose of this program is to provide funding to states/territories to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures. Public Health Service (PHS) Act authorizes the Secretary to utilize resources to control epidemics of any disease. These funds are to be used in conjunction with the Ryan White HIV/AIDS Program (RWHAP) Part B ADAP administered by the HRSA, HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP).
ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health care coverage assistance). HRSA will base ADAP ERF awards upon your ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists.
An ADAP must have written policies and procedures for managing a waiting list that include:
- Criteria that are fair and equitable;
- Compliance with state/territory laws and regulations that impact establishment of a waiting list;
- A means for public input and communications to the public;
- Methods for monitoring the waiting list to ensure that the policies and procedures are consistently followed across the state/territory; and
- A revisions and appeals process.
Funding Information
- Award Ceiling: $10,000,000
- The period of performance is April 1, 2023 through March 31, 2024 (1 year)
Eligibility Criteria
- State government
- All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the following requirements:
- Eligible applicants are limited to RWHAP Part B states/territories that need additional funding:
- to reduce or eliminate an existing ADAP waiting list,
- to actively prevent the implementation of an ADAP waiting list,
- to address a projected increase in treatment needs aligned with ending the HIV epidemic in the U.S., and/or
- to address other unanticipated increases in the number of clients in the program due to new diagnosis, re-engagement in care, loss of income, and/or loss of health care coverage.
States/territories that do not currently meet one or more of the above criteria are not eligible to apply.
For more information, visit Grants.gov.